$GNLX Cashflow Statement | Understand Stock

$GNLX

$2.05 +$0.14 (7.33%) Close

$GNLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Cash Flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Net amortization of premiums and discounts on short-term investments
Accretion of discount on marketable securities
Right-of-use asset
Amortization of debt discount
Stock compensation
Fair value of restricted stock units
Cost of stock option repricing
Cost of stock option modifications and repricing
Gain on extinguishment of accounts payable
Debt extinguishment costs
Fair value of warrants issued in connection with the conversion of convertible notes payable
Changes in operating assets and liabilities:
Prepaid expenses and other assets
Accounts payable and accrued expenses
Accrued payroll and payroll taxes
Accrued interest payable
Deferred revenue
Net cash used in operating activities
Cash Flows from investing activities
Purchases of property and equipment
Purchase of marketable securities
Proceeds from sales and maturities of marketable securities
Net cash provided by (used in) investing activities
Cash Flows from financing activities
Proceeds from notes payable - shareholders
Repayment of notes payable - shareholders
Payment of deferred offering costs
Proceeds from common stock issued
Proceeds from common stock issued for cash in connection with the closing of a second public offering
Proceeds from common stock issued in connection with the Company’s equity award programs
Proceeds from the exercise of stock options
Proceeds from the exercise of stock warrants
Gross proceeds
Net cash provided by financing activities
Net decrease in cash, cash equivalents and restricted cash
BEGINNING OF PERIOD
END OF PERIOD
Interest paid
Supplemental non-cash financing disclosures:
Effect of the extension of right-of-use asset and operating lease
Reclassification of deferred offering costs to shareholders’ equity
Reclassification of warrant liabilities to shareholders’ equity
Conversion of convertible notes payable, accrued interest and loan fees to shareholders’ equity
Conversion of preferred stock to common stock
Conversion of dividends payable to shareholders’ equity
Conversion of notes payable-shareholders and accrued interest to shareholders’ equity
Unrealized gain on investments
Unrealized (loss) gain on marketable securities
Initial recognition of right-of-use asset obtained in exchange for operating lease liabilities

Comments